FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948374482> ?p ?o ?g. }

• W2948374482 endingPage "111454" @default.
• W2948374482 startingPage "111454" @default.
• W2948374482 abstract "Mesenchymal stem cells (MSCs) have been widely documented for their potential role in the treatment of various clinical disorders, including acute lung injury (ALI). ALI represents a clinical syndrome associated with histopathological diffuse alveolar damage. Recent evidence has demonstrated that exosomes derived from MSCs may serve as a reservoir of anti-apoptotic microRNAs (miRs) conferring protection from certain diseases. Hence, the current study was performed with the aim of investigating whether MSCs-exosomal miR-30b-3p could confer protection against ALI. A bioinformatic analysis and a dual luciferase assay were initially performed to verify that SAA3 was highly-expressed in ALI which was confirmed to be a target gene of miR-30b-3p. Next, the lipopolysaccharide (LPS)-treated type II alveolar epithelial cells (AECs) (MLE-12) were transfected with mimics or inhibitors of miR-30b-3p, or sh-SAA3. It was revealed that LPS induced AEC apoptosis, which could be inhibited by overexpressing miR-30b-3p by down-regulating the expression of SAA3. After co-culture of PKH26-labeled exosomes with MLE-12 cells, we found that the number of PKH26-labeled exosomes endocytosed by MLE-12 cells gradually increased. Furthermore, the LPS-treated MLE-12 cells co-cultured with MSC-exosomes overexpressing miR-30b-3p exhibited increased miR-30b-3p, decreased SAA3 level, as well as increased cell proliferation, accompanied by diminished cell apoptosis in LPS-treated MLE-12 cells. Finally, the protective effect of MSCs-exosomal miR-30b-3p on the AECs in vivo was investigated in an ALI mouse model with tail vein injection of MSC-exosomes with elevated miR-30b-3p, showing that overexpression of miR-30b-3p in MSC-exosomes conferred protective effects against ALI. Taken together, these findings highlighted the potential of MSC-exosomes overexpressing miR-30b-3p in preventing ALI. The exosomes derived from MSCs hold potential as future therapeutic strategies in the treatment of ALI." @default.
• W2948374482 created "2019-06-14" @default.
• W2948374482 creator A5014471230 @default.
• W2948374482 creator A5019115888 @default.
• W2948374482 creator A5026984704 @default.
• W2948374482 creator A5046712784 @default.
• W2948374482 creator A5049692788 @default.
• W2948374482 creator A5053384952 @default.
• W2948374482 creator A5064204355 @default.
• W2948374482 creator A5071178943 @default.
• W2948374482 creator A5071375375 @default.
• W2948374482 date "2019-10-01" @default.
• W2948374482 modified "2023-09-29" @default.
• W2948374482 title "Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3" @default.
• W2948374482 cites W102886457 @default.
• W2948374482 cites W1458687811 @default.
• W2948374482 cites W1479842253 @default.
• W2948374482 cites W1966347977 @default.
• W2948374482 cites W1999128589 @default.
• W2948374482 cites W2008906556 @default.
• W2948374482 cites W2025540345 @default.
• W2948374482 cites W2037130549 @default.
• W2948374482 cites W2062634724 @default.
• W2948374482 cites W2069056995 @default.
• W2948374482 cites W2072386858 @default.
• W2948374482 cites W2076738567 @default.
• W2948374482 cites W2090335937 @default.
• W2948374482 cites W2097386197 @default.
• W2948374482 cites W2107277218 @default.
• W2948374482 cites W2108488469 @default.
• W2948374482 cites W2109179710 @default.
• W2948374482 cites W2111813641 @default.
• W2948374482 cites W2120651904 @default.
• W2948374482 cites W2121875081 @default.
• W2948374482 cites W2124033527 @default.
• W2948374482 cites W2124104087 @default.
• W2948374482 cites W2155323171 @default.
• W2948374482 cites W2178829033 @default.
• W2948374482 cites W2233288893 @default.
• W2948374482 cites W2290608784 @default.
• W2948374482 cites W2318129076 @default.
• W2948374482 cites W2336786371 @default.
• W2948374482 cites W2340318031 @default.
• W2948374482 cites W2342676755 @default.
• W2948374482 cites W2514636631 @default.
• W2948374482 cites W2546088870 @default.
• W2948374482 cites W2555060163 @default.
• W2948374482 cites W2589546201 @default.
• W2948374482 cites W2610344331 @default.
• W2948374482 cites W2614635477 @default.
• W2948374482 cites W2622510831 @default.
• W2948374482 cites W2730282981 @default.
• W2948374482 cites W2750416656 @default.
• W2948374482 cites W2752881420 @default.
• W2948374482 cites W2768055411 @default.
• W2948374482 cites W2781628997 @default.
• W2948374482 cites W2792733823 @default.
• W2948374482 cites W2805041171 @default.
• W2948374482 cites W2806321323 @default.
• W2948374482 cites W2885775802 @default.
• W2948374482 cites W2904628185 @default.
• W2948374482 cites W2944801133 @default.
• W2948374482 doi "https://doi.org/10.1016/j.yexcr.2019.05.035" @default.
• W2948374482 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31170401" @default.
• W2948374482 hasPublicationYear "2019" @default.
• W2948374482 type Work @default.
• W2948374482 sameAs 2948374482 @default.
• W2948374482 citedByCount "90" @default.
• W2948374482 countsByYear W29483744822019 @default.
• W2948374482 countsByYear W29483744822020 @default.
• W2948374482 countsByYear W29483744822021 @default.
• W2948374482 countsByYear W29483744822022 @default.
• W2948374482 countsByYear W29483744822023 @default.
• W2948374482 crossrefType "journal-article" @default.
• W2948374482 hasAuthorship W2948374482A5014471230 @default.
• W2948374482 hasAuthorship W2948374482A5019115888 @default.
• W2948374482 hasAuthorship W2948374482A5026984704 @default.
• W2948374482 hasAuthorship W2948374482A5046712784 @default.
• W2948374482 hasAuthorship W2948374482A5049692788 @default.
• W2948374482 hasAuthorship W2948374482A5053384952 @default.
• W2948374482 hasAuthorship W2948374482A5064204355 @default.
• W2948374482 hasAuthorship W2948374482A5071178943 @default.
• W2948374482 hasAuthorship W2948374482A5071375375 @default.
• W2948374482 hasConcept C104317684 @default.
• W2948374482 hasConcept C145059251 @default.
• W2948374482 hasConcept C153911025 @default.
• W2948374482 hasConcept C190283241 @default.
• W2948374482 hasConcept C198826908 @default.
• W2948374482 hasConcept C203014093 @default.
• W2948374482 hasConcept C20518536 @default.
• W2948374482 hasConcept C2778754761 @default.
• W2948374482 hasConcept C28328180 @default.
• W2948374482 hasConcept C502942594 @default.
• W2948374482 hasConcept C54009773 @default.
• W2948374482 hasConcept C54355233 @default.
• W2948374482 hasConcept C81885089 @default.
• W2948374482 hasConcept C86803240 @default.
• W2948374482 hasConcept C95444343 @default.

• next